Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 55154-7634

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 55154-7634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (1843d24f 2e80 4749 Becc 9def6c3607c7 01)

FDA Label Image

1 (1843d24f 2e80 4749 Becc 9def6c3607c7 02)

FDA Label Image

Torrent Logo (1843d24f 2e80 4749 Becc 9def6c3607c7 03)

FDA Label Image

6ba56251 E43c 4e34 A37f 42a542550c05 00

6ba56251 E43c 4e34 A37f 42a542550c05 00
Pantoprazole Sodium Delayed-Release Tablets, USP are a prescription drug that comes in a pack of 10 tablets with each tablet containing 40mg of pantoprazole. The tablets are intended to be swallowed whole and not crushed, chewed or split. The dosage of the medicine should be taken as specified in the product packaging, which also contains necessary precautions and warnings. The packaging should be stored between 20° - 25 C (88" - 77 F) with excursions permitted 1015°-30° C (59° - 86° F) and a pharmacist should dispense medication with a medication guide. The product is manufactured in India and distributed in the USA by Major Pharmaceuticals and Cardinal Health. The package is not child-resistant and should be kept out of reach from children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.